A Study of the Pharmacokinetics of Uprifosbuvir (MK-3682) and Ruzasvir (MK-8408) in Participants With Moderate and Severe Hepatic Insufficiency (MK-3682-029)
Clinical trial NCT02666352 · COMPLETED
Trial details
- NCT number
- NCT02666352
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-01-22
- Primary completion
- 2017-01-16
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.